Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman, Kewei Chen, Xiaofen Liu, Daniel J. Bandy, Meixiang Yu, Wendy Lee, Napatkamon Ayutyanont, Jennifer S. Keppler, Stephanie Reeder, Jessica B. S. Langbaum, Gene E. Alexander, William E. Klunk, Chester A. Mathis, Julie C. Price, Howard Jay Aizenstein, Steven T. DeKosky, Richard J. Caselli. Proceedings of the National Academy of Sciences, 2009-04-03
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Fibrillar amyloid-beta (Abeta) is found in the brains of many cognitively normal older people. Whether or not this reflects a predisposition to Alzheimer's disease (AD) is unknown. We used Pittsburgh Compound B (PiB) PET to characterize the relationship between fibrillar Abeta burden and this predisposition in cognitively normal older people at 3 mean levels of genetic risk for AD. Dynamic PiB PET scans, the Logan method, statistical parametric mapping, and automatically labeled regions of interest (ROIs) were used to characterize and compare cerebral-to-cerebellar PIB distribution volume ratios, reflecting fibrillar Abeta burden, in 28 cognitively normal persons (mean age, 64 years) with a reported family history of AD and 2 copies, 1 copy, and no copies of the apolipoprotein E (APOE) epsilon4 allele. The 8 epsilon4 homozygotes, 8 heterozygotes, and 12 noncarriers did not differ significantly in terms of age, sex, or cognitive scores. Fibrillar Abeta was significantly associated with APOE epsilon4 carrier status and epsilon4 gene dose in AD-affected mean cortical, frontal, temporal, posterior cingulate-precuneus, parietal, and basal ganglia ROIs, and was highest in an additional homozygote who had recently developed mild cognitive impairment. These findings suggest that fibrillar Abeta burden in cognitively normal older people is associated with APOE epsilon4 gene dose, the major genetic risk factor for AD. Additional studies are needed to track fibrillar Abeta accumulation in persons with different kinds and levels of AD risk; to determine the extent to which fibrillar Abeta, alone or in combination with other biomarkers and risk factors, predicts rates of cognitive decline and conversion to clinical AD; and to establish the role of fibrillar Abeta imaging in primary prevention trials.
What this study adds
Evidence grade: Not rated
In 28 cognitively normal people with a family history of Alzheimer's disease, fibrillar amyloid burden on PiB PET was associated with how many copies of the APOE epsilon4 gene variant they carried. The authors call for more studies on whether this amyloid predicts cognitive decline.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Reiman, E. M., Chen, K., Liu, X., Bandy, D. J., Yu, M., Lee, W., et al. (2009). Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0900345106
Vancouver
Reiman EM, Chen K, Liu X, Bandy DJ, Yu M, Lee W, et al. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences. 2009. doi:10.1073/pnas.0900345106. PMID: 19346482.
BibTeX
@article{reiman2009-19346482,
author = {Reiman, Eric M. and Chen, Kewei and Liu, Xiaofen and Bandy, Daniel J. and Yu, Meixiang and Lee, Wendy and Ayutyanont, Napatkamon and Keppler, Jennifer S. and Reeder, Stephanie and Langbaum, Jessica B. S. and Alexander, Gene E. and Klunk, William E. and Mathis, Chester A. and Price, Julie C. and Aizenstein, Howard Jay and DeKosky, Steven T. and Caselli, Richard J.},
title = {{Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease}},
journal = {Proceedings of the National Academy of Sciences},
year = {2009},
doi = {10.1073/pnas.0900345106},
pmid = {19346482},
url = {https://doi.org/10.1073/pnas.0900345106}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 17 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Why it matters
In 28 cognitively normal people with a family history of Alzheimer's disease, fibrillar amyloid burden on PiB PET was associated with how many copies of the APOE epsilon4 gene variant they carried. The authors call for more studies on whether this amyloid predicts cognitive decline.
New to this subject? Start with our plain-English guide: Genetics →
How this study scored 54/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 51 of the 95 points we could judge it on, which is 54 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Proceedings of the National Academy of Sciences) |
| Journal's citation record | 4 / 4 | Proceedings of the National Academy of Sciences: journal h-index 1,167 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 788 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 41.5 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 6 / 6 | Cited 41.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 74 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Richard J. Caselli: h-index 84 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Pittsburgh: institution h-index 1,470 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19346482) |
| Free to read | 2 / 2 | Free to read |
| Points | 51 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 95 points we could judge it on is 54 out of 100. |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.